Prognostic Significance of Lymph Node Metastases in Small Intestinal Neuroendocrine Tumors
- 5 January 2015
- journal article
- research article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 101 (1) , 58-65
Abstract
Background/Aims: Current staging guidelines for small intestinal neuroendocrine tumors (SI-NETs) differentiate between the presence (N1) and absence (N0) of lymph node (LN) metastases. However, the prognostic significance of the extent of LN involvement remains unknown. In this study, we used data from a population-based cancer registry to examine whether involvement of a higher number of LNs is associated with worse survival. Methods: We used the Surveillance, Epidemiology, and End Results (SEER) database to identify patients with histologically confirmed, surgically resected SI-NETS diagnosed between 1988 and 2010. Patients were classified into three groups by the LN ratio (number of positive LNs/number of total LNs examined, LNR): ≤0.2, >0.2-0.5, and >0.5. We used the Kaplan-Meier method and Cox models to assess NET cancer-specific survival differences (up to 10 years from diagnosis) according to LNR status. Results: We identified 2,984 surgically resected patients with stage IIIb (N1, M0) SI-NETs with detailed LN data. More than half of the NETs were located in the ileum. A higher LNR was significantly associated with worse NET cancer-specific survival (p < 0.0001). Ten-year NET-specific survival was 85, 77, and 74% for patients in the ≤0.2, >0.2-0.5, and >0.5 LNR groups, respectively. In stratified analyses, higher LNR groups had worse survival only in early tumor (T1, T2) disease (p < 0.0001). Conclusions: The extent of LN involvement provides independent prognostic information on patients with LN-positive SI-NETs. This information may be used to identify patients at high risk of recurrence and inform decisions about the use of adjuvant therapy.Keywords
This publication has 28 references indexed in Scilit:
- A Retrospective Analysis of Incidence and Its Associated Risk Factors of Upper Urinary Tract Recurrence following Radical Cystectomy for Bladder Cancer with Transitional Cell Carcinoma: The Significance of Local Pelvic Recurrence and Positive Lymph NodePLOS ONE, 2014
- Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancerAnnals of Oncology, 2014
- Lymph node staging in colorectal cancer: Old controversies and recent advancesWorld Journal of Gastroenterology, 2013
- Evaluation of Lymph Nodes in Patients with Colon Cancer Undergoing Colon Resection: A Population‐based StudyWorld Journal of Surgery, 2012
- The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine TumorsEndocrinology and Metabolism Clinics of North America, 2011
- Neuroendocrine tumors of midgut and hindgut origin: Tumor‐node‐metastasis classification determines clinical outcomeCancer, 2011
- Biochemical Testing for Neuroendocrine TumorsPancreas, 2009
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumoursGut, 2006
- Stage at diagnosis is a key explanation of differences in breast cancer survival across EuropeInternational Journal of Cancer, 2003